Anixa Retained Earnings from 2010 to 2024

ANIX Stock

USD 3.20 0.14 4.58%

Anixa Biosciences Retained Earnings yearly trend continues to be fairly stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that Anixa Biosciences retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

1985-10-31

Previous Quarter

-234.6 M

Current Value

-237.9 M

Quarterly Volatility

67.1 M

Black Monday

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Anixa Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anixa Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 216.9 K, Selling General Administrative of 4.2 M or Total Revenue of 229.4 K, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0 or PTB Ratio of 4.39. Anixa financial statements analysis is a perfect complement when working with Anixa Biosciences Valuation or Volatility modules.

Check out the analysis of Anixa Biosciences Correlation against competitors.

For more information on how to buy Anixa Stock please use our How to Invest in Anixa Biosciences guide.

Latest Anixa Biosciences' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Anixa Biosciences over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Anixa Biosciences' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anixa Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (228.2 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Anixa Retained Earnings Regression Statistics

	Arithmetic Mean	(163,898,845)
	Coefficient Of Variation	(33.15)
	Mean Deviation	37,931,643
	Median	(170,170,209)
	Standard Deviation	54,325,182
	Sample Variance	2951.2T
	Range	223.9M
	R-Value	(0.84)
	Mean Square Error	931.2T
	R-Squared	0.71
	Significance	0.000086
	Slope	(10,214,083)
	Total Sum of Squares	41317.2T

Anixa Retained Earnings History

	2024	-195.1 M
	2023	-205.4 M
	2022	-228.2 M
	2021	-218.4 M
	2020	-204.8 M
	2019	-191.8 M
	2018	-181.8 M

Other Fundumenentals of Anixa Biosciences

Retained Earnings Total Equity

Anixa Biosciences Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Net Receivables	Accounts Payable	Short Term Investments	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Capital Surpluse	Long Term Investments	Intangible Assets	Long Term Debt Total	Short Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	-0.55	-0.67	-0.29	0.99	-0.34	-0.61	0.81	-0.32	0.64	0.01	0.98	0.83	-0.48	-0.16	0.26	-0.49	0.95	0.95	0.92
Total Stockholder Equity	0.98		-0.59	-0.65	-0.46	1.0	-0.27	-0.63	0.8	-0.44	0.7	0.08	0.99	0.86	-0.43	-0.25	0.26	-0.55	0.93	0.94	0.92
Net Debt	-0.55	-0.59		0.29	0.41	-0.56	0.19	0.37	0.01	0.27	-0.34	0.14	-0.49	-0.46	0.03	0.26	-0.16	0.32	-0.62	-0.63	-0.37
Retained Earnings	-0.67	-0.65	0.29		0.12	-0.67	0.85	0.02	-0.59	0.34	-0.15	0.6	-0.67	-0.77	0.85	-0.08	-0.69	0.74	-0.58	-0.59	-0.67
Total Liab	-0.29	-0.46	0.41	0.12		-0.38	-0.25	0.35	-0.22	0.76	-0.59	-0.34	-0.42	-0.43	-0.09	0.51	-0.06	0.49	-0.25	-0.27	-0.32
Total Current Assets	0.99	1.0	-0.56	-0.67	-0.38		-0.3	-0.62	0.82	-0.39	0.68	0.05	0.99	0.85	-0.46	-0.2	0.27	-0.52	0.94	0.95	0.93
Net Receivables	-0.34	-0.27	0.19	0.85	-0.25	-0.3		-0.28	-0.2	0.04	0.26	0.84	-0.28	-0.41	0.81	-0.25	-0.6	0.49	-0.25	-0.27	-0.29
Accounts Payable	-0.61	-0.63	0.37	0.02	0.35	-0.62	-0.28		-0.52	0.26	-0.63	-0.55	-0.64	-0.44	-0.22	0.53	0.38	-0.06	-0.65	-0.65	-0.65
Short Term Investments	0.81	0.8	0.01	-0.59	-0.22	0.82	-0.2	-0.52		-0.29	0.59	0.19	0.86	0.71	-0.51	-0.11	0.18	-0.41	0.7	0.7	0.87
Common Stock	-0.32	-0.44	0.27	0.34	0.76	-0.39	0.04	0.26	-0.29		-0.55	-0.09	-0.43	-0.48	0.21	0.28	-0.29	0.62	-0.26	-0.28	-0.35
Property Plant Equipment	0.64	0.7	-0.34	-0.15	-0.59	0.68	0.26	-0.63	0.59	-0.55		0.54	0.71	0.57	0.04	-0.46	-0.08	-0.25	0.64	0.64	0.66
Current Deferred Revenue	0.01	0.08	0.14	0.6	-0.34	0.05	0.84	-0.55	0.19	-0.09	0.54		0.1	-0.05	0.55	-0.39	-0.54	0.36	0.06	0.05	0.13
Net Tangible Assets	0.98	0.99	-0.49	-0.67	-0.42	0.99	-0.28	-0.64	0.86	-0.43	0.71	0.1		0.86	-0.46	-0.27	0.23	-0.52	0.91	0.92	0.94
Capital Surpluse	0.83	0.86	-0.46	-0.77	-0.43	0.85	-0.41	-0.44	0.71	-0.48	0.57	-0.05	0.86		-0.53	-0.27	0.52	-0.61	0.85	0.86	0.93
Long Term Investments	-0.48	-0.43	0.03	0.85	-0.09	-0.46	0.81	-0.22	-0.51	0.21	0.04	0.55	-0.46	-0.53		-0.47	-0.78	0.72	-0.33	-0.34	-0.46
Intangible Assets	-0.16	-0.25	0.26	-0.08	0.51	-0.2	-0.25	0.53	-0.11	0.28	-0.46	-0.39	-0.27	-0.27	-0.47		0.53	-0.2	-0.24	-0.26	-0.29
Long Term Debt Total	0.26	0.26	-0.16	-0.69	-0.06	0.27	-0.6	0.38	0.18	-0.29	-0.08	-0.54	0.23	0.52	-0.78	0.53		-0.72	0.24	0.25	0.29
Short Term Debt	-0.49	-0.55	0.32	0.74	0.49	-0.52	0.49	-0.06	-0.41	0.62	-0.25	0.36	-0.52	-0.61	0.72	-0.2	-0.72		-0.36	-0.37	-0.44
Net Invested Capital	0.95	0.93	-0.62	-0.58	-0.25	0.94	-0.25	-0.65	0.7	-0.26	0.64	0.06	0.91	0.85	-0.33	-0.24	0.24	-0.36		1.0	0.91
Net Working Capital	0.95	0.94	-0.63	-0.59	-0.27	0.95	-0.27	-0.65	0.7	-0.28	0.64	0.05	0.92	0.86	-0.34	-0.26	0.25	-0.37	1.0		0.92
Capital Stock	0.92	0.92	-0.37	-0.67	-0.32	0.93	-0.29	-0.65	0.87	-0.35	0.66	0.13	0.94	0.93	-0.46	-0.29	0.29	-0.44	0.91	0.92

Click cells to compare fundamentals

About Anixa Biosciences Financial Statements

Anixa Biosciences investors use historical fundamental indicators, such as Anixa Biosciences' Retained Earnings, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Anixa Biosciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Retained Earnings	-205.4 M	-195.1 M
Retained Earnings Total Equity	-196.5 M	-206.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Anixa Stock Analysis

When running Anixa Biosciences' price analysis, check to measure Anixa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anixa Biosciences is operating at the current time. Most of Anixa Biosciences' value examination focuses on studying past and present price action to predict the probability of Anixa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anixa Biosciences' price. Additionally, you may evaluate how the addition of Anixa Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC